NOCIL.NS(NOCIL.NS)
NOCIL.NS
No analyst ratings available
No analyst price targets available for NOCIL.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $15.30B | $17.83B | $17.94B |
| Low | $14.78B | $15.91B | $16.62B |
| High | $17.00B | $21.33B | $20.76B |
| EBITDA Avg | $2.09B | $2.44B | $2.45B |
| Low | $2.02B | $2.18B | $2.27B |
| High | $2.33B | $2.92B | $2.84B |
| EBIT Avg | $1.53B | $1.79B | $1.80B |
| Low | $1.48B | $1.59B | $1.67B |
| High | $1.70B | $2.14B | $2.08B |
| Net Income Avg | $973M | $1.44B | $900M |
| Low | $821M | $1.02B | $814M |
| High | $1.19B | $2.14B | $1.08B |
| EPS Avg | $5.37 | $7.70 | $5.37 |
| Low | $4.90 | $6.10 | $4.86 |
| High | $7.10 | $12.80 | $6.47 |
| Analysts (Rev / EPS) | 5 / 4 | 5 / 4 | 1 / 2 |